China Releases New Drug GMPs; Domestic Consolidation Expected To Accelerate
This article was originally published in The Pink Sheet Daily
Executive Summary
Multinational pharmas operating in China will need to review their manufacturing practices comprehensively to ensure full compliance because China's GMP 2010 standards contain numerous unique requirements that are different from the U.S. and ICH/EU GMPs.